Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Canioni

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
European Journal of Haematology|February 14, 2012
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitorSophie Georgin-Lavialle, Ludovic Lhermitte, Felipe Suarez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2013
Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort studyBenjamin Terrier, Dominique Costagliola, Sophie Prevot, et al.
Transplantation|July 26, 2005
Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV statusHélène A Poirel, Alain Bernheim, Anouck Schneider, et al.
The Lancet. Haematology|July 13, 2019
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 studyFranck Morschhauser, Steven Le Gouill, Pierre Feugier, et al.
Human Pathology|April 18, 2017
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patientsLuc Xerri, Sarah Huet, Jeffrey M Venstrom, et al.
Plos One|January 28, 2014
ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseasesGandhi Damaj, Magalie Joris, Olivia Chandesris, et al.
Pediatrics|December 14, 2011
Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic reviewSandrine Leroy, Despina Moshous, Olivier Cassar, et al.
Lancet (London, England)|November 29, 2011
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trialChristian Récher, Bertrand Coiffier, Corinne Haioun, et al.
The American Journal of Surgical Pathology|August 2, 2021
High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3BCamille Laurent, José Adélaïde, Arnaud Guille, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participantsJudith Trotman, Marion Fournier, Thierry Lamy, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Haematology|February 14, 2012
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitorSophie Georgin-Lavialle, Ludovic Lhermitte, Felipe Suarez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2013
Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort studyBenjamin Terrier, Dominique Costagliola, Sophie Prevot, et al.
Transplantation|July 26, 2005
Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV statusHélène A Poirel, Alain Bernheim, Anouck Schneider, et al.
The Lancet. Haematology|July 13, 2019
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 studyFranck Morschhauser, Steven Le Gouill, Pierre Feugier, et al.
Human Pathology|April 18, 2017
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patientsLuc Xerri, Sarah Huet, Jeffrey M Venstrom, et al.
Plos One|January 28, 2014
ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseasesGandhi Damaj, Magalie Joris, Olivia Chandesris, et al.
Pediatrics|December 14, 2011
Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic reviewSandrine Leroy, Despina Moshous, Olivier Cassar, et al.
Lancet (London, England)|November 29, 2011
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trialChristian Récher, Bertrand Coiffier, Corinne Haioun, et al.
The American Journal of Surgical Pathology|August 2, 2021
High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3BCamille Laurent, José Adélaïde, Arnaud Guille, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participantsJudith Trotman, Marion Fournier, Thierry Lamy, et al.
Pageof 10